Smoking cessation & nicotine de-addiction products market estimated to be valued US$ 9,014 Mn in 2018 and poised to grow at CAGR of 12.7% over 2019-2025. Market for smoking cessation & nicotine de-addiction products projected to reach US$ 18,489 Mn by 2025 owing to growing awareness regarding smoking cessation and availability of wider product choices. Do policy changes bring positive impact on smoking cessation and nicotine de-addiction products market:
Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. These government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players.
Major Key Players of the Smoking Cessation & Nicotine De-addiction Products Market are:Cipla Ltd. (India), GlaxoSmithKline plc. (UK), ITC Limited (India), Johnson & Johnson Services Inc. (U.S), NJOY, Inc. (U.S), Novartis AG (Switzerland), Pfizer, Inc. (U.S), Takeda Pharmaceuticals Co. Ltd. (Japan), VMR Products, LLC (U.S)
Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. These government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players.
Major Key Players of the Smoking Cessation & Nicotine De-addiction Products Market are:Cipla Ltd. (India), GlaxoSmithKline plc. (UK), ITC Limited (India), Johnson & Johnson Services Inc. (U.S), NJOY, Inc. (U.S), Novartis AG (Switzerland), Pfizer, Inc. (U.S), Takeda Pharmaceuticals Co. Ltd. (Japan), VMR Products, LLC (U.S)
No comments:
Post a Comment